Sort
64,565 grants matching “drug discovery”
Pathogenesis and treatment of autoinflammatory diseases i.e.NOMID,DIRA,CANDLE
$1,020,597Raphaela Goldbach-Mansky · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
CORE--Drug, Discovery, Design and Synthesis
$1,020,466Gunda I. Georg · University Of Kansas Medical Center · U54 · FY2011 · HD
CRISPR/Cas-mediated development of an RNAi rat model system
$1,020,397Prem Khovabutr Premsrirut · Mirimus, Inc. · R44 · FY2020 · OD
Project 2 - Novel Therapeutics for Emerging Alphavirus
$1,020,148Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2020 · AI
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia
$1,020,000Bjorn C Knollmann · Vanderbilt University Medical Center · R35 · FY2019 · HL
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
$1,020,000Frederick R Blattner · Dnastar, Inc. · R44 · FY2024 · AI
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia
$1,020,000Bjorn C Knollmann · Vanderbilt University Medical Center · R35 · FY2023 · HL
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia
$1,020,000Bjorn C Knollmann · Vanderbilt University Medical Center · R35 · FY2025 · HL
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia
$1,020,000Bjorn C Knollmann · Vanderbilt University Medical Center · R35 · FY2021 · HL
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia
$1,020,000Bjorn C Knollmann · Vanderbilt University Medical Center · R35 · FY2022 · HL
Toward a Mechanism-Based Approach to Treating Cardiac Arrhythmia
$1,020,000Bjorn C Knollmann · Vanderbilt University Medical Center · R35 · FY2020 · HL
Enhancing access to multi-omic data assets in the AMP-AD research ecosystem
$1,020,000Lara M Mangravite · Sage Bionetworks · U24 · FY2020 · AG
Project 2 - Novel Therapeutics for Emerging Alphavirus
$1,019,887Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2021 · AI
A New Small-Molecule Kinase Inhibitor for Airway Disease
$1,019,816Kay O Broschat · Nupeak Therapeutics, Inc. · R42 · FY2025 · HL
Center of Excellence for High Throughput Proteogenomic Characterization
$1,019,814Steven A. Carr · Broad Institute, Inc. · U24 · FY2024 · CA
Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable
$1,019,771Mark R Denison · University Of Alabama At Birmingham · U19 · FY2017 · AI
Novel Adjuvants/Delivery Systems for Biodefense Vaccines
$1,019,625Novartis Vaccines And Diagnostics, Inc. · U01 · FY2003 · AI
Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC)
$1,019,186Bradley T. Keller · Accuronix Therapeutics, Inc. · R42 · FY2022 · CA
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
$1,019,120Mayland F Chang · University Of Notre Dame · R01 · FY2011 · AI
"Discovery and Development of Anti-Diabetic Drugs."
$1,018,907Gerard M Housey · Housey Pharmaceutical Research Lab · R44 · FY2011 · DK
Senior Leadership
$1,018,903Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2016 · CA
Tri-Institutional Tuberculosis Research Advancement Center (TRAC)
$1,018,797Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · P30 · FY2024 · AI
Development Therapeutics Branch-Translational Medicine and Therapeutics Group
$1,018,780Anish Thomas · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
In Vivo Proof of Concept and Target Identification Using Small Molecule Stimulators of Brown Adipogenesis
$1,018,644Olivier Boss · Energesis Pharmaceuticals, Inc. · R44 · FY2021 · DK
A New Small-Molecule Kinase Inhibitor for Airway Disease
$1,018,383Kay O Broschat · Nupeak Therapeutics, Inc. · R42 · FY2024 · HL